Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Weiskirchen

Showing results (71-80 of 501) with videos related to

Pageof 51
Sort By:
Frontiers in Cellular and Infection Microbiology|April 4, 2025
Editorial: The microbiome in the development of gastrointestinal diseasesAmedeo Amedei, Ralf Weiskirchen
Frontiers in Medicine|November 5, 2025
The role of copper dysregulation in Wilson disease: an expert opinionWolfgang Stremmel, Ralf Weiskirchen
Expert Opinion on Therapeutic Targets|May 8, 2026
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver diseaseRalf Weiskirchen, Amedeo Lonardo
Annals of Translational Medicine|May 14, 2021
Therapeutic strategies in Wilson disease: pathophysiology and mode of actionWolfgang Stremmel, Ralf Weiskirchen
Frontiers in Pharmacology|February 9, 2026
Silent inflammation: a hidden cause of liver fibrosisHans-Theo Schon, Ralf Weiskirchen
Frontiers in Pharmacology|February 28, 2018
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!Steffen K Meurer, Ralf Weiskirchen
Current Issues in Molecular Biology|August 27, 2025
Editorial for the Special Issue "Advances in Molecular Biology Methods in Hepatology Research"Dileep G Nair, Ralf Weiskirchen
Clinical Biochemistry|September 28, 2018
Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassayJosef van Helden, Ralf Weiskirchen
Cytokine & Growth Factor Reviews|November 9, 2015
The PDGF system and its antagonists in liver fibrosisErawan Borkham-Kamphorst, Ralf Weiskirchen
Frontiers in Pharmacology|September 15, 2016
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryHans-Theo Schon, Ralf Weiskirchen
Pageof 51

Showing results (71-80 of 501) with videos related to

Sort By:
Pageof 51
Frontiers in Cellular and Infection Microbiology|April 4, 2025
Editorial: The microbiome in the development of gastrointestinal diseasesAmedeo Amedei, Ralf Weiskirchen
Frontiers in Medicine|November 5, 2025
The role of copper dysregulation in Wilson disease: an expert opinionWolfgang Stremmel, Ralf Weiskirchen
Expert Opinion on Therapeutic Targets|May 8, 2026
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver diseaseRalf Weiskirchen, Amedeo Lonardo
Annals of Translational Medicine|May 14, 2021
Therapeutic strategies in Wilson disease: pathophysiology and mode of actionWolfgang Stremmel, Ralf Weiskirchen
Frontiers in Pharmacology|February 9, 2026
Silent inflammation: a hidden cause of liver fibrosisHans-Theo Schon, Ralf Weiskirchen
Frontiers in Pharmacology|February 28, 2018
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition!Steffen K Meurer, Ralf Weiskirchen
Current Issues in Molecular Biology|August 27, 2025
Editorial for the Special Issue "Advances in Molecular Biology Methods in Hepatology Research"Dileep G Nair, Ralf Weiskirchen
Clinical Biochemistry|September 28, 2018
Cross-method comparison of serum androstenedione measurement with respect to the validation of a new fully automated chemiluminescence immunoassayJosef van Helden, Ralf Weiskirchen
Cytokine & Growth Factor Reviews|November 9, 2015
The PDGF system and its antagonists in liver fibrosisErawan Borkham-Kamphorst, Ralf Weiskirchen
Frontiers in Pharmacology|September 15, 2016
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic InjuryHans-Theo Schon, Ralf Weiskirchen
Pageof 51